NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

Travel, commodity stocks lift British shares on vaccine optimism

Published 11/23/2020, 04:43 PM
Updated 11/23/2020, 04:50 PM
© Reuters.
UK100
-
AZN
-
FTMC
-
FTNMX502010
-
FTNMX405010
-
FTNMX551030
-
FTNMX601010
-
MRNA
-
BNTX
-

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* FTSE 100 up 0.3%, FTSE 250 adds 0.7%

Nov 23 (Reuters) - London stocks rose on Monday, extending
their three-week rally, as travel and commodity stocks jumped
after positive vaccine data from AstraZeneca, with hopes of a
post Brexit-trade deal with European Union, also lifting the
mood.
The blue-chip FTSE 100 index .FTSE gained 0.3%, after
drugmaker AstraZeneca Plc AZN.L said its vaccine for the novel
coronavirus, developed along with the University of Oxford,
could be around 90% effective without any serious side effects.
Energy .FTNMX0530 , mining .FTNMX1770 and aero
.FTNMX2710 were among the biggest gainers on the index.
The domestically focused mid-cap FTSE 250 .FTMC added 0.7%
with travel and leisure .FTNMX5750 stocks providing the
biggest boost.
UK markets have already jumped more than 14% this month,
after Pfizer-BioNTech PFE.N BNTX.O and Moderna 's MRNA.O
vaccines' showed similar responses in preventing COVID-19 based
on interim data from a late-stage trial, raising hopes of a
sooner-than expected recovery from the pandemic-driven
recession. Adding to the mood, British health minister said UK aims to
rollout a COVID-19 vaccine before Christmas, with life getting
back to normal after Easter.


Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.